Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Visningar
• 08/04/23
0
0
Bädda in
administrator
Prenumeranter
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna